Jeremy Richards

Jeremy Richards
Contributor since: 2008
Vical: 2012 Should Be A Huge Year
Geron Is Now A Bargain Buy
Rexahn Is a Bargain Buy
Novavax Has Over 400% Upside Potential
Zalicus Offers Excellent Upside